Perampanel and levetiracetam both control SeLECTS with minor sleep differences
Analysis Neurology / Neuropharmacology Hypothesis-generating Grade: Very Low
Yan L, Xie L, Li T, et al.
Aug 8, 2026 · Published in: Epilepsy & Behavior : E&B
PER may enhance sleep in children with SeLECTS.
WHO decision leaflet cuts inappropriate antibiotic use in simulation
Analysis Infectious Disease / Antimicrobials Hypothesis-generating Grade: Low
Sievert EDC, Gross R, Korn L, et al.
Aug 8, 2026 · Published in: Applied Psychology. Health and Well-being
Decision support reduces inappropriate antibiotic use effectively.
NTM in Oncology: Dual Beta-Lactam Signals Warrant Study
Analysis Infectious Disease / Antimicrobials Hypothesis-generating Grade: Very Low
Pasikhova Y, Snyder M, Morrison A, et al.
Aug 8, 2026 · Published in: Open Forum Infectious Diseases
NTM infections in cancer patients demand complex treatment approaches.
Ketamine Versus Pregabalin for Opioid Sparing After Spinal Fusion
Analysis Medication Safety Hypothesis-generating Grade: Low
Coffin M, Azhar MZ, Shepherd W, et al.
Aug 7, 2026 · Published in: Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Ketamine might outperform pregabalin in reducing opioid use post-spinal fusion.
DOAC After LAAC Beats DAPT Only in Observational Data
Analysis Cardiology / Anticoagulation Inconclusive Grade: Low
Alam U, Ahmed AU, Javed J, et al.
Aug 7, 2026 · Published in: Journal of Thrombosis and Thrombolysis
DOACs may outperform DAPT after LAAC in NVAF patients.
SGLT2 Inhibitors Show No Significant Serious UTI Excess
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Moderate
Matteucci A, Di Fusco SA, Bonanni M, et al.
Aug 7, 2026 · Published in: Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences
SGLT2 inhibitors show no significant rise in UTI risk.
Intracranial B7-H3 CAR-T Shows Early Promise in Recurrent Glioblastoma
Analysis Oncology Pharmacy Hypothesis-generating Grade: Very Low
Aug 7, 2026 · Published in: Nature Medicine
CAR-T cell therapy offers new hope for recurrent glioblastoma.
Psilocybin Feasible for Treatment-Resistant Depression in NHS Setting
Analysis Psychiatry / Psychopharmacology Hypothesis-generating Grade: Low
Aug 7, 2026 · Published in: Nature Medicine
Psilocybin shows promise for treatment-resistant major depression.
AAIITO Expert Consensus Reframes Mild-to-Moderate Asthma Toward Proactive Control
Consensus Statement Pulmonology / Respiratory Confirmatory Grade: Low
Martini M, Cecchi L, Musarra A, et al.
Aug 6, 2026 · Published in: Respiratory Medicine
Expert consensus offers new guidelines for mild-to-moderate asthma management.
Talquetamab Efficacy in Multiple Myeloma Shown Over 3 Years
Analysis Oncology Pharmacy
Rasche L, Schinke C, Touzeau C, et al.
Aug 6, 2026 · Published in: Blood
Long-term talquetamab offers hope for relapsed/refractory multiple myeloma.
Esketamine Cuts Pediatric Emergence Delirium After Sevoflurane by Two-Thirds
Analysis Pediatrics Confirmatory Grade: Moderate
Lateiresh M, Louat A, Alwefati M, et al.
Aug 6, 2026 · Published in: Paediatric Anaesthesia
Esketamine reduces emergence delirium in children post-anesthesia.
Pediatric Melatonin Linked to Small REM Sleep Reduction
Analysis Internal Medicine / Hospital Medicine Hypothesis-generating Grade: Low
Juginovic A, Rodman L
Aug 6, 2026 · Published in: JAMA Network Open
Melatonin may reduce REM sleep in children without affecting total sleep time.
Incretin Agonists as Rescue Therapy After Bariatric Surgery
Analysis Endocrinology / Diabetes / Obesity Hypothesis-generating Grade: Low
Rosenior-Patten O, Lees Z, Rowe R, et al.
Aug 6, 2026 · Published in: Diabetes, Obesity and Metabolism
This meta-analysis quantifies weight loss from liraglutide, semaglutide, and tirzepatide in patients with suboptimal response after metabolic bariatric surgery, a population systematically excluded from pivotal obesity trials.
Real-world lecanemab in Chinese patients: low ARIA, financial-driven discontinuation
Analysis Neurology / Neuropharmacology Hypothesis-generating Grade: Low
Wu H, Chen Q, Fang M, et al.
Aug 6, 2026 · Published in: Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Lecanemab shows safety but no cognitive boost in real-world AD study.
Dexmedetomidine vs Propofol: No Ventilation or Mortality Edge
Analysis Critical Care / ICU Confirmatory Grade: Moderate
Zhang XY, Qin S, Liu MJ, et al.
Aug 6, 2026 · Published in: Frontiers in Neurology
Dexmedetomidine might reduce ICU delirium compared to propofol.